4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0000899243-20-033903
10% owner sold 64,624 shares at an average $80.14 ($5,179,285)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BRATTON DOUGLAS K 10% owner | 2020-12-11 | Sale | −46,799 | $80.05 | $3,746,442 | 401,236 | I: show line 1 in the form |
| BRATTON DOUGLAS K 10% owner | 2020-12-14 | Sale | −16,949 | $80.35 | $1,361,774 | 384,287 | I: show line 2 in the form |
| BRATTON DOUGLAS K 10% owner | 2020-12-14 | Sale | −876 | $81.13 | $71,068 | 383,411 | I: show line 3 in the form |
| Open-market sales · 64,624 sh · avg $80.14 · $5,179,285 | |||||||
Loading xslF345X03/doc4.xml…